Commercialization· September 10, 2026 · 21 min read
ChinaMedGlobal: Checking Access Assumptions in a Licensed Drug Data Room
By Ran Chen#Market Access#Coverage Access#Payer Policy
Topic
Coverage Access
Formulary tiers, utilization management, patient support, and the access layer GoodRx and drug labels do not explain.
Pricing & Access· September 10, 2026 · 23 min read
TrialEndpoints: 'No Response Recorded' Is Not the Same as Treatment Failure
Approvals· September 5, 2026 · 29 min read
Etcamah's Sept 4 Approval Does Not Rewrite Orserdu PAs or ODAC's ctDNA Dispute
Approvals· September 4, 2026 · 36 min read
Lirafugratinib's Sept 27 PDUFA Does Not Rewrite Pemazyre PAs or Lytgobi CDx
By Ran Chen#PDUFA Date#FDA Approval#NDA Approval
Approvals· September 3, 2026 · 34 min read
Injectafer's Phosphate Boxed Warning Does Not Rewrite J1439, AP Generics, or Oral-Iron PAs
By Ran Chen#Boxed Warning#Label Warnings#FDA Approval
Approvals· September 2, 2026 · 33 min read
Aqneursa's Sept 19 A-T PDUFA Does Not Rewrite NPC-Only PAs or the 15 kg Floor
By Ran Chen#PDUFA Date#FDA Approval#NDA Approval
Approvals· September 1, 2026 · 29 min read
Camzyos's Sept 30 Adolescent PDUFA Does Not Rewrite Adult REMS or Age-18 PA Gates
By Ran Chen#PDUFA Date#FDA Approval#NDA Approval
Policy· August 31, 2026 · 16 min read
CMS Part D 340B Repository: Voluntary Files Do Not Replace Prescriber Math
By Ran Chen#340B#Medicare Part D#IRA Negotiation
Policy· August 31, 2026 · 18 min read
CMS RAPID Is an IDE Presubmission NCD Clock, Not Post-Authorization Coverage
Approvals· August 31, 2026 · 18 min read
Stelara's Pediatric UC License Does Not Write Wezlana Pediatric IBD Substitution
By Ran Chen#Biosimilars#Interchangeability#Purple Book